top of page

Search

Great news that Synapix Bio have secured £13.2m to fund clinical trials for H-ABC/Tubb4a!

habcfoundationuk
May 10, 2023
1 min read

Oxford biotech firm secures £13.2m to develop first treatment for rare, incurable, deadly disease. (synaptixbio.com)

Recent Posts

In a major article for Drug Discovery World, Dan Williams discussed the opportunities for ASO-based therapies

In a major article for Drug Discovery World, Dan Williams discussed the opportunities for ASO-based therapies

Lyonette Designs donating 10% of sales to H-ABC Foundation UK

Lyonette Designs donating 10% of sales to H-ABC Foundation UK

Addressing the Funding Crisis for Special Needs Education in the UK

Being a parent of a child suffering from Hypomyelination with Atrophy of the Basal Ganglia and Cerebellum (H-ABC), a condition caused by...

Comentarios

bottom of page